Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.
Gurrea-Rubio M, Wu Q, Amin MA, Tsou PS, Campbell PL, Amarista CI, Ikari Y, Brodie WD, Mattichak MN, Muraoka S, Randon PM, Lind ME, Ruth JH, Mao-Draayer Y, Ding S, Shen X, Cooney LA, Lin F, Fox DA. Gurrea-Rubio M, et al. Among authors: ikari y. Cancer Immunol Immunother. 2024 Jan 27;73(2):34. doi: 10.1007/s00262-023-03578-1. Cancer Immunol Immunother. 2024. PMID: 38280067 Free PMC article.
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer Cells.
Gurrea-Rubio M, Wu Q, Amin MA, Tsou PS, Campbell PL, Amarista CE, Ikari Y, Brodie WD, Mattichak MN, Muraoka S, Randon PM, Lind ME, Ruth JH, Mao-Draayer Y, Ding S, Shen X, Cooney LA, Lin F, Fox DA. Gurrea-Rubio M, et al. Among authors: ikari y. Res Sq [Preprint]. 2023 Oct 9:rs.3.rs-3405677. doi: 10.21203/rs.3.rs-3405677/v1. Res Sq. 2023. Update in: Cancer Immunol Immunother. 2024 Jan 27;73(2):34. doi: 10.1007/s00262-023-03578-1 PMID: 37886483 Free PMC article. Updated. Preprint.
Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis.
Muraoka S, Brodie WD, Mattichak MN, Gurrea-Rubio M, Ikari Y, Foster C, Amin MA, Khanna N, Amin H, Campbell PL, Vichaikul S, Model EN, Omara MM, Petrovski S, Kozicki K, Amarista C, Webber A, Ali M, Palisoc PJ, Hervoso J, Ruth JH, Tsoi LC, Varga J, Gudjonsson JE, Khanna D, Fox DA, Tsou PS. Muraoka S, et al. Among authors: ikari y. Arthritis Rheumatol. 2025 Jan;77(1):80-91. doi: 10.1002/art.42973. Epub 2024 Sep 18. Arthritis Rheumatol. 2025. PMID: 39175116 Free PMC article.
An aspirin-free strategy for percutaneous coronary intervention in patients with diabetes: a pre-specified subgroup analysis of the STOPDAPT-3 trial.
Yamamoto K, Natsuaki M, Watanabe H, Morimoto T, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Ikari Y, Kurita T, Kaitani K, Sugimoto A, Ogata N, Ikuta A, Hashimoto K, Ishibashi Y, Masuda K, Miyabe T, Ono K, Kimura T. Yamamoto K, et al. Among authors: ikari y. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 23:pvae075. doi: 10.1093/ehjcvp/pvae075. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39444052
Cardiomyopathy with anti-mitochondrial M2 antibody-positive myositis.
Yoshikawa M, Nagai T, Iwaki D, Yuge M, Amemiya K, Ikeda Y, Ikari Y. Yoshikawa M, et al. Among authors: ikari y. J Med Ultrason (2001). 2024 Oct 15. doi: 10.1007/s10396-024-01506-z. Online ahead of print. J Med Ultrason (2001). 2024. PMID: 39404997 No abstract available.
543 results